UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A Amendment No. 1 (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2002 [ ] TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from ______________ to ________________ Commission file number - 000-22813 CENTERPOINT CORPORATION ------------------------------------------------------ (Exact name of registrant as specified in its charter) Delaware 13-3853272 ------------------------------- ------------------------------------ (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18 East 50th St. 10 Floor New York, New York 10022 -------------------------------------------------- (Address of principal executive offices - Zip code) Registrant's telephone number, including area code: (212) 758-6622 Former name, former address and former fiscal year, if changed since last report. Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ___ No X APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS: Indicate by checkmark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ____ No ____ APPLICABLE ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. Common stock, par value $.01 per share, 6,005,339 shares outstanding as of July 19, 2002. TABLE OF CONTENTS Page Part I - Financial Information 2 UNAUDITED CONSOLIDATED BALANCE SHEET 3 UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED March 31, 2002 4 UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY 5 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS 6 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 7-12 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 13 Part II - Other Information 14 Item 1. Legal Proceedings 14 Item 2. Changes in Securities 15 Item 3. Defaults Upon Senior Securities 15 Item 4. Submission of Matters to a Vote of Security Holders 15 Item 5. Other Information 15 Item 6. Exhibits and Reports on Form 8-K 15 SIGNATURES 16 1 CENTERPOINT CORPORATION March 31, 2002 Part I - Financial Information 2 CENTERPOINT CORPORATION UNAUDITED CONSOLIDATED BALANCE SHEET March 31, 2002 Mar. 31 2002 ASSETS $'000 Current: Cash and cash equivalents $ 19 Prepaid expenses 41 ------- TOTAL CURRENT ASSETS 60 ------- Other Assets: Investment in Bion 11,763 Deferred debt cost 472 ------- TOTAL OTHER ASSETS 12,235 ------- TOTAL ASSETS 12,295 ======= LIABILITIES Accounts payable 87 Amounts due to related and affiliated parties 43 Accrued expenses and other payables 109 ------- TOTAL CURRENT LIABILITIES 239 ------- Commitments and Contingencies Stockholders' equity: Common stock, par value $0.01 per share: Authorised 20,250,000 shares; 6,005,339 shares outstanding 50 Additional paid-in capital 19,116 Accumulated deficit (7,110) ------- Total Stockholders' equity 12,056 ------- LIABILITIES & SHAREHOLDERS' EQUITY 12,295 ======= See Notes to Consolidated Financial Statements 3 CENTERPOINT CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS 3 Months ended March 31, 2002 and 2001 Mar. 31 Mar. 31 2002 2001 US $'000 US $'000 Revenue (Expenses): General and administrative expenses (287) (45) Write-down of TRG loan (1,061) Loss on foreign currency translation (667) Interest income 8 162 ---------- ---------- Net income (2,007) 117 ---------- ---------- Income attributable to common shareholders (2,007) 117 ========== ========== Earnings Per Share: Basic and Diluted $ (0.33) $ 0.02 Weighted Average Number of Shares Outstanding During the Period: Basic and Diluted 6,002,908 5,999,089 ========== ========== See Notes to Consolidated Financial Statements 4 CENTERPOINT CORPORATION UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY March 31, 2002 Accumulated Additional Other SHARE- Common Stock Paid-In Comprehensive Accumulated HOLDERS Shares Amount Capital TRG Loan Income Deficit EQUITY $'000 $'000 $'000 $'000 $'000 $'000 Balance January 1, 2002 5,999,089 50 18,635 (4,316) (667) (5,103) 8,599 Realization of Accumulated Comprehensive Income 667 667 Shares issued for services 6,250 9 - - - 9 Assignment of TRG Loan - 4,316 - - 4,316 Deferred Debt Cost 472 472 Net Income (2,007) (2,007) ----------------------------------------------------------------------------- Balance March 31, 2002 6,005,339 50 19,116 - - (7,110) 12,056 ============================================================================= See Notes to Consolidated Financial Statement 5 CENTERPOINT CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOW March 31, 2002 Mar. 31 Mar. 31 2002 2001 $'000 $'000 Net income from continuing operations (2,007) 117 Adjustments to reconcile net income to net cash provided by operating activities: Write-down of TRG Loan 1,061 - Stock issuance for services 9 - Realized loss on foreign currency translation 667 - Other operating activities 1 Changes in assets and liabilities: Prepaid expenses 2 18 Accounts payable and accrued expenses 71 (21) Related party payables 3 (80) Accrued expenses (48) - ------ ----- Net cash provided by operating activities (242) 35 ------ ----- Investing activities Investment in Bion (8,500) - ------ ----- Net cash used in financing activities (8,500) - ------ ----- Net increase/(decrease) in cash (8,742) 35 Effects of exchange rate changes on cash - 21 Cash, beginning of period 8,761 1,095 ------ ----- Cash, end of period 19 1,151 ====== ===== Supplemental information on non-cash investing activities: Assignment of Loan to TRG as consideration for the purchase of Bion common stock 3,263 - ====== ===== See Notes to Financial Statements 6 CENTERPOINT CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2002 1. Basis of Presentation The accompanying unaudited consolidated condensed financial statements of Centerpoint Corporation (the "Company") have been prepared in accordance with the instructions to Form 10-QSB. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. For a summary of the Registrant's accounting principles, and other footnote information, reference is made to the Form 10-K for the year ended December 31, 2001. All adjustments necessary for the fair presentation of the results of operations for the interim periods covered by this report have been included. All of such adjustments are of a normal and recurring nature. The results of operations for the three months ended March 31, 2002 are not necessarily indicative of the operating results for the full year. The Company was originally incorporated in Delaware on August 9, 1995 under the name of North Atlantic Acquisition Corp. to serve as a vehicle to effect a merger, exchange of capital stock, asset acquisition or other business combination with an operating business. On August 27, 1997 the Company consummated an initial public offering consisting of 800,000 Units and 150,000 shares of Class B Common Stock, with each Unit consisting of one share of Class A Common Stock and one warrant to purchase shares of Class A Common Stock, which resulted in net proceeds to the Company of approximately $8,000,000. On August 18, 1998, the Company and Trident Rowan Group, Inc. ("TRG" or "Trident Rowan") entered into a definitive agreement and plan of merger and reorganization, as amended (the "Merger Agreement"), pursuant to which Moto Guzzi Corp. merged with and into the Company, with the Company as the surviving corporation (the "Merger"). Prior to the Merger, TRG and its majority-owned subsidiary, OAM S.p.A. ("OAM"), together owned all the outstanding common stock of Moto Guzzi Corp. The Merger, which occurred on March 5, 1999, was treated as a reverse acquisition of the Company. The results of operations and cash flows prior to the date of the merger are those of Moto Guzzi Corp. Following the Merger, the Company changed its name to Moto Guzzi Corporation, adopted the December 31 financial reporting year of Moto Guzzi Corp. and financial statements were prepared using the accounting principles of Moto Guzzi Corp. In September 2000, the Company sold all its operating subsidiaries to Aprilia S.p.A. ("Aprilia") and changed its name to Centerpoint Corporation. The financial statements for the period ended March 31, 2002 are shown in U.S. dollars because all of the Company's material operating entities were based and operated in the U.S. For the similar period ending March 31, 2001, the Company's financial statements were translated to U.S. dollars since the functional currency was the Italian lire. 7 In December 2001, the Board of the Company met to evaluate the alternative strategies and investments available to the Company. Investec Ernst & Co., who had been hired in June 2001 to assist in this process, presented to the Board their conclusions on a number of potential investments. After review of the possible investments, the Board resolved to approve the acquisition of 19,000,000 shares of Bion Environmental Technologies, Inc., a publicly-held Colorado corporation ("Bion"). Bion is an environmental service company focused on the needs of confined animal feeding operations. Bion is engaged in two main areas of activity: waste stream remediation and organic soil and fertilizer production. Bion's waste remediation service business provides confined animal feeding operations (primarily in the swine and dairy industries) with treatment for the animal waste outputs. In this regard, Bion treats their entire waste stream in a manner which cleans and reduces the waste stream thereby mitigating pollution of the air, water (both ground and surface) and soil, while creating value-added organic soil and fertilizer products. Bion's soil and fertilizer products are being used for a variety of applications including school athletic fields, golf courses and home and garden applications. On January 15, 2002, the Company closed the transaction with Bion by purchasing 19,000,000 shares of restricted stock of Bion in exchange for approximately $8.5 million in cash (substantially all of the Company's cash), the TRG Promissory Note (including accrued interest and reduced by the write- down see below), and the assignment of 65% of the Company's claims with respect to the escrow accounts and claims against IMI (see below). Unrestricted stock of Bion is traded on the OTC/BB market under the ticker "BION". The 65% of the claims that were assigned to Bion from the Company are the Company's claims against Aprilia, S.p.A., an Italian corporation ("Aprilia"), the purchaser of the Company's motorcycle operations and Banca di Intermediazione Mobiliare IMI S.p.A., an Italian corporation ("IMI"), the investment banker for the Company in the transaction. The Aprilia claim is for funds paid to Aprilia, though disputed by the Company, from an escrow account set up for contingent liabilities related to the sale of the motorcycle operations. The claim against IMI is with regard to a dispute in calculating the fee they received as investment banker in the sale of the motorcycle operations to Aprilia. The total of these two claims is approximately $7,945,000. The 65% of these claims that Bion received for the sale of its shares of common stock to the Company was valued in the Bion transaction at $2,487,000. This represents a 52% discount from the full amount of the claim for an aggregate discounted value of $3,826,154. The $3,826,154 value ascribed to the claim was arrived at through an internal allocation made by Bion management based on its own evaluation of the relevant facts and circumstances and its review of a fairness opinion that was provided by an investment banking firm with regard to the transaction as a whole, and there is no assurance that this, or any, amount will ever be recovered. On January 15, 2002, effective immediately prior to the Company's transaction with Bion, the Company's note receivable from TRG for $4,324,274 was written down by $1,061,274 as part of the transaction. The Company also assigned the entire loan of $3,263,000, after the write down, to Bion for the purchase of Bion's shares of common stock by the Company. (See below and Form 8-K dated January 15, 2002). 8 In addition, an escrow account that was set up for contingent liabilities for the sale of the motorcycle operations and eventual rights to the balance of these funds amounting to approximately $875,000 which is not valued on the Company's books. Immediately upon consummation of this transaction, Bion purchased a 57.7% majority interest in the Company from OAM. The total consideration paid by Bion consisted of (i) $3,700,000 in cash, (ii) the assignment of the TRG Promissory Note (including accrued interest and reduced by the write-down see above) and related loan guarantees, (iii) the assignment of the 65% interest in the Company's claims with respect to the escrow accounts and claims against IMI (see above), (iv) the issuance of 1,000,000 shares of Bion's common stock, and (v) the issuance of a warrant to acquire 1,000,000 shares of Bion's common stock at a price of $0.90, with expiration date of January 10, 2007. Under the Subscription Agreement and related Registration Rights Agreement, Bion agreed among other things (i) file a with SEC a Registration Statement with respect to the Bion Shares, as soon as practicable, and within 90 days of the Company's filing with the SEC of its December 31, 2001 Form 10-K, which was filed on July 2, 2002 and to use its best efforts to cause such Registration Statement to be declared effective as soon as practicable thereafter, (ii) to use its best efforts to cause the Bion Shares to be distributed to the Company's common stockholders in a tax efficient manner in accordance with applicable law, and (iii) to use its best efforts to hold an Annual Meeting of Bion Shareholders during 2002, in accordance with its by- laws and applicable law (a meeting was held April 4, 2002). It is expected that the distribution will occur during the second half of calendar 2002. When that distribution occurs, approximately 11,000,000 of Bion's shares will be distributed back to Bion. Bion has advised the Company that it intends to cancel such shares. David Mitchell, a director of the Company, is the Chairman, President, Board member and a principal stock and warrant holder of Bion. Additionally a portion of the proceeds of the Bion Investment were used to pay off $718,485 of indebtedness of Bion owed to Mr. Mitchell. On January 24, 2002, David Mitchell was elected as the Company's President and CEO. David Mitchell is a founder, stockholder, option holder, former CEO of the Company and currently is the only director of the Company. Following the Bion Investment and Bion acquisition of Centerpoint Shares, all of the Company's directors, other than David Mitchell, resigned from their positions on the Company's Board of Directors. Bill Spier, one of the Company's Directors until he resigned on January 24, 2002, sits on Bion's advisory board. On January 21, 2002, Howard Chase, a director of the Company until he resigned on January 15, 2002, joined the Board of Directors of Bion. The Company has a cash flow deficit from operations and relies on the financial support of Bion, its majority shareholder. Taking into consideration that Bion has incurred operating losses and has, in addition, an accumulated deficit and shortage of funds, there can be no assurance that any funds required during the next twelve months or thereafter can be generated from operations or that if such required funds are not internally generated that such funds will be available from external sources. 9 2. Related Party Transactions On June 13, 2001 the Company, TRG and OAM entered into the TRG Loan Agreement ("TRG Loan") wherein subject to the terms and certain conditions set forth therein the Company agreed to lend TRG $4,200,000. The loan bears interest at a rate of 5% per annum, is repayable in full on the earlier of June 13, 2002 and the date on which the Company causes or permits a liquidation of the Company, and was secured by the 300,000 shares of the Company common stock currently owned by the TRG and 1,200,000 of the shares of the Company common stock owned by OAM. In connection with the TRG Loan, OAM also entered into the OAM Guaranty wherein it guaranteed TRG's obligations under the TRG Loan Agreement. OAM's liability to the Company under the OAM Guaranty is limited to the value of the Company shares pledged by OAM. On January 15, 2002, in connection with the transaction with Bion, the Company assigned the loan to Bion for the purchase of Bion's shares of common stock. Bion then assigned the loan to OAM for the purchase of the Company's common stock. Prior to these transactions, the Company wrote-off $1,061,274 of this loan (See Note 1 - - Basis of Presentation). For the three months ending March 31, 2002, interest of $8,055 was recorded on the TRG Loan which represents interest accrued through January 15, 2002, the date of the Bion transaction. On March 14, 2002, the Company and Bion entered in an agreement effective January 15, 2002 where the Company will pay $12,000 a month for management services, support staff and office space. In addition, Bion will advance to the Company sums needed to bring its filings with the SEC current, distribute Bion shares to its shareholders, to locate and acquire new business opportunities and for on-going expenses. Bion shall have no obligation to make any advances in excess of $500,000. All sums due Bion shall be evidenced by a convertible revolving promissory note. As additional consideration, Bion received a warrant to purchase 1,000,000 shares of the Company's common stock at $3.00 per share until March 14, 2007. This warrant was valued at $472,000 using the Black-Scholes pricing model and will be amortized over the life of the warrant. As of March 31, 2002 Bion had advanced the Company a total of $42,683. 3. Outstanding Claims Aprilia Claims under the Share Purchase Agreement; Request for Arbitration Pursuant to the terms, and subject to the conditions, of the Share Purchase Agreement and the Escrow Agreement relating to the sale of Moto Guzzi's operating subsidiaries, Lit. 9,375 million (approximately US$ 4,548,000) of the proceeds of the sale were placed into escrow. 10 By letter dated December 21, 2000, legal counsel for Aprilia filed a claim against Centerpoint under the Share Purchase Agreement alleging (i) that it had failed to receive a resignation and release from Mr. Roeth, an executive and director of MGI Motorcycle GmbH, a subsidiary of the Company before the sale to Aprilia, and (ii) that the campaign recall with respect to certain Moto Guzzi motorcycles was more critical than that forecast in the Management Date Financial Statements and August 3, 2000 letter. By letter dated February 5, 2001 Centerpoint's Italian legal counsel responded to the December 21, 2000 letter specifically denying the alleged claims and requesting that the parties meet to negotiate a release of the escrow funds, as provided for in the August 3, 2000 letter. On June 4, 2001 Aprilia's legal counsel sent a letter to Centerpoint which reiterated the claims in its December 21, 2000 letter and alleged the following: (i) that the cost of the recall campaign was estimated by Aprilia to be approximately Lit. 4,500 million (approximately US$ 2,183,000), which exceeded the Management Date Financial Statement amount with respect to the recall campaign by Lit. 2,676 million (approximately US$ 1,298,000), (ii) that technical problems related to various motorcycles were likely to cost Aprilia approximately Lit. 5,308 million (approximately US$ 2,575,000), and that such technical problems had not been disclosed to Aprilia in connection with the sale of the Moto Guzzi operations to Aprilia, and that Aprilia was entitled to reimbursement of such costs, (iii) that Aprilia was entitled to reimbursement of Lit. 148.5 million (approximately US$ 72,000) incurred by Aprilia in connection with the termination of Mr. Roeth, an executive of MGI Motorcycle GmbH, (iv) that Aprilia was entitled to reimbursement of Lit. 378 million (approximately US$ 183,000) in respect of unjustified credit notes issued by MGI Motorcycle GmbH in favor of dealers and distributors, and (v) that breaches of accounting principles by Moto Guzzi North America entitled it to claims against Centerpoint in the amount of Lit. 1,100 million (approximately US$ 534,000) (collectively with (i), (ii), (iii) and (iv), the "Alleged Claims"). On July 13, 2001 Centerpoint's Italian counsel sent a letter to Aprilia's counsel contesting all of the Alleged Claims. By letter dated July 13, 2001 Aprilia requested that IMI, the escrow agent under the Escrow Agreement, pay them Lit. 7,611 million (approximately US$ 3,692,000) in respect of the Alleged Claims. On July 26, 2001, in spite of being aware of Centerpoint contesting of each of the Alleged Claims and its intention to seek arbitration, IMI advised Centerpoint that it had paid Lit. 7,611 million (approximately US$ 3,692,000) from the escrow account to Aprilia in respect of the Alleged Claims. Pursuant to the Share Purchase Agreement and Escrow Agreement, each of which provides that disputes among the parties be arbitrated, the Company filed with the International Arbitration Court of the International Chamber of Commerce a Request for Arbitration in Accordance with Article 4 of the ICC Rules of Arbitration relating to the Alleged Claims and the payment by IMI. Subsequent to the Company's filing, a committee was formed in Milano, Italy to hear the case. The Company is requesting restitution of the Lit. 7,611 million (approximately US$ 3,692,000) paid to Aprilia, plus interest and costs. The Arbitration committee was constituted on November 16, 2001, and a decision is expected to be rendered within twelve to eighteen months of the original filing date. 11 Dispute with IMI Regarding its Fee IMI, the Company's investment adviser in connection with the sale of the operating subsidiaries, acted as fiduciary for the closing. At the Closing, but without the prior approval, knowledge or consent of the Company, IMI was paid Lit. 11,401 million, (approximately US$ 5,532,000) in respect of fees and expenses claimed by IMI to be due it under its engagement letter with TRG and OAM. Since early July 2000, the Company and TRG have disputed IMI's interpretation of the calculation of the fee due it under its engagement letter, following indication by IMI of its basis of calculation. The dispute relates to the respective interpretations of the Company, TRG and IMI of the term "Total Transaction Value" as that term is used in the engagement letter. Since that time, the Company and TRG discussed and sought to negotiate with IMI concerning its alleged amount of the fee. IMI refused to engage in negotiations and did not present any calculation of the fee to the Company or TRG prior to the closing. After the closing and actual payment to IMI of the alleged fee, IMI then presented a calculation and an invoice to the Company for fees and expenses alleged by IMI to be due it under the engagement letter in the amount of Lit. 11,401 million (approximately US$ 5,532,000). In addition to disputing the amount of the fee paid to IMI, the Company believes that IMI had no right to cause its fee to be deducted from the sale proceeds, as the Company was not a party to the engagement letter, and did not consent to any such deduction. On February 11, 2002 the Company brought a suit against IMI before the Civil Section of the Court of Milano, seeking reimbursement of Lit. 8,766 million (approximately US$ 4,253,000) of the Lit. 11,401 million (US$ 5,532,000) paid to IMI at the closing. The first hearing in the case, originally scheduled for May 27, 2002, was postponed to July 2, 2002 and as at May 15, 2002 IMI has not yet filed its defenses. On July 2, 2002, IMI and an attorney for the Company appeared before the Examining Judge of the Civil Section of the Court of Milano. IMI filed a defense plea asking for the rejection of the Company's claim. No discussion was made on the merit of the case and the Judge fixed the next hearing for November 15, 2002 at which time the Judge will interrogate both parties and see if it is possible for a settlement. 4. Stockholders' Equity During the quarter the following transactions occurred: On February 5, 2002 the Company issued 6,250 shares of the Company's common stock to an individual for legal services provided to the Company. Equity was increased by $9,375 for the value of the shares issued based on the closing price of the stock of $1.50 on the date of issuance. 12 CENTERPOINT CORPORATION Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations Three Months Ended March 31, 2002 2001 $'000 $'000 Revenue (Expenses): General and administrative expenses (287) (45) Write-down of TRG loan (1,061) - Loss on foreign currency translation (667) - Interest income 8 162 ------ ------ Net income attributable to common shareholders (2,007) 117 ====== ====== During the three months ended March 31, 2002, the Company recorded administrative expenses of $287,000 including $134,000 for costs paid to an investment banker for the Bion transaction, and additional administrative costs including legal fees of $72,058, management fee of $30,000, consulting fees of $27,500, insurance expense of $20,605 and other minor expenses. The Company recorded interest income of $8,348 during the period, primarily from interest earned on the TRG loan. In the corresponding period in 2001, the Company recorded interest income of $162,000 on fixed interest securities and selling, general and administrative expenses of $45,000 principally in respect of compliance costs on continuing operations. The Company also had an expense for the write-down of the TRG loan by $1,061,274. This was recorded in connection with the assignments made to Bion in connection with the Company's acquisition of Bion's common stock in January 2002. (See Note 1 to the financial statements.) An additional expense of $667,000 was charged for the realization of foreign exchange losses. Liquidity and Financial Resources At the time of the filing of this Report in July 2002, the Company has approximately $14,000 of cash. In order to meet future costs, such as sums needed to bring its filings with the SEC current, to distribute Bion shares to its shareholders, to locate and acquire new business opportunities and for ongoing expenses, loans from Bion will need to be made to the Company. Bion has no obligation to make any advances in excess of $500,000 under its management agreement with the Company. All sums due Bion are to be evidenced by a convertible revolving promissory note. Taking into consideration that Bion has incurred operating losses and has, in addition, an accumulated deficit and limited funds, there can be no assurance that funds required during the next twelve months or thereafter will be available from external sources. 13 Part II - Other Information Item 1. Legal Proceedings Pursuant to the Share Purchase Agreement and the Escrow Agreement relating to the sale of Moto Guzzi's operating subsidiaries, Lit. 9,375 million of the proceeds of the sale were placed into escrow. In December 21, 2000 and June 2001, legal counsel for Aprilia filed claims against the Company under the Share Purchase Agreement alleging various breaches of representations and warranties by Company. On July 23, 2001, in spite of being aware of the Company contesting of each of the alleged claims and its intention to seek arbitration, IMI advised the Company that it had paid Lit. 7,610 million from the escrow account to Aprilia in respect of the alleged claims. Pursuant to the Share Purchase Agreement and Escrow Agreement, each of which provides that disputes among the parties be arbitrated, the Company filed with the International Arbitration Court of the International Chamber of Commerce a Request for Arbitration in Accordance with Article 4 of the ICC Rules of Arbitration relating to the Alleged Claims and the payment by IMI. Subsequent to the Company's filing, a committee was formed in Milano, Italy to hear the case. The company is requesting restitution of the Lit. 7,610 million (approximately US$3,692,000) paid to Aprilia, plus interest and costs. The Arbitration committee was constituted on November 16, 2001, and a decision is expected to be rendered within twelve to eighteen months of the original filing date. Further details concerning the alleged claims and proceedings are set forth under "Aprilia Claims Under the Stock Purchase Agreement" above, which is incorporated herein by reference. At the September 7, 2000 closing of the sale of the subsidiaries, in accordance with an invoice previously submitted to them by IMI, but without the prior approval, knowledge or consent of the Company, IMI was paid Lit. 11,401 million, in respect of fees and expenses claimed by IMI to be due it under its engagement letter with TRG and OAM. Since early July 2000, the Company and TRG have disputed IMI's interpretation of the calculation of the fee due it under its engagement letter, following initial indication by IMI of its basis of calculation. On February 11, 2002 the Company brought a suit against IMI before the Civil Section of the Court of Milano, seeking reimbursement of Lit. 8,766 million (approximately US$4,253,000) of the Lit. 11,401 million (US$5,532,000) paid to IMI at the closing. The first hearing in the case, originally scheduled for May 27, 2002, was postponed to July 2, 2002. On July 2, 2002, IMI and an attorney for the Company appeared before the Examining Judge of the Civil Section of the Court of Milano. IMI filed a defense plea asking for the rejection of the Company's claim. No discussion was made on the merit of the case and the Judge fixed the next hearing for November 15, 2002 at which time the Judge will interrogate both parties and see if it is possible for a settlement. 14 Item 2. Changes in Securities The following securities were sold in the quarter ended March 31, 2002 without registration under the Securities Act of 1933, as amended: On February 5, 2002 we issued 6,250 shares of the Company's common stock to Michael Beckert, an attorney, based on a price per share of $1.50 for fees earned for legal services for the period ending January 31, 2002. In connection with this transaction we relied on the exemption from registration afforded by Section 4(2) and/or other provisions of the Securities Act of 1933, as amended. Mr. Beckert is a sophisticated investor and had access to complete information concerning the Company. The certificate representing the common stock issued bears a restrictive legend concerning the transfer of the shares and stop transfer instructions have been provided to our transfer agent. Item 3. Defaults Upon Senior Securities None Item 4. Submission of Matters to a Vote of Security Holders None Item 5. Other Information None Item 6. Exhibits and Reports on Form 8-K Exhibits -------- None Reports on Form 8-K ------------------- The following current report on Form 8-K was filed during the three months ended March 31, 2002: Form 8-K dated January 15, 2002: Items 1,5 & 7 15 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned, thereunto duly authorized. CENTERPOINT CORPORATION September 27, 2002 /s/ David Mitchell ------------------------------------ David Mitchell President September 27, 2002 /s/ David Fuller ------------------------------------ David Fuller Principal Accounting Officer CERTIFICATIONS I, David J. Mitchell, certify that: 1. I have reviewed this quarterly report on Form 10-QSB of Centerpoint Corporation; 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; and 3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report. Dated: September 27, 2002 /s/ David J. Mitchell ------------------------------------ David J. Mitchell Chief Executive Officer (Principal Executive Officer) 16 I, David Fuller, certify that: 1. I have reviewed this quarterly report on Form 10-QSB of Centerpoint Corporation; 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; and 3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report. Dated: September 27, 2002 /s/ David Fuller ------------------------------------ David Fuller Principal Accounting Officer (Principal Financial Officer) CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER OF CENTERPOINT CORPORATION PURSUANT TO 18 U.S.C. SECTION 1350 We certify that, to the best of our knowledge, the Quarterly Report on Form 10-QSB of Centerpoint Corporation for the period ending March 31, 2002: (1) complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bion Environmental Technologies, Inc. /s/ David J. Mitchell /s/ David Fuller - -------------------------------- ---------------------------------- David J. Mitchell David Fuller Chief Executive Officer Chief Financial Officer September 27, 2002 September 27, 2002 17